Advanced in Multiple Carboxylase Deficiency

Olivier Gout

CHU D'Amiens
Amiens, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Multiple Carboxylase Deficiency
CHU D'Amiens
Amiens, FR 
OverviewLocationsClinical Research

Overview

Olivier Gout practices in Amiens, France. Mr. Gout is rated as an Advanced expert by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Biotinidase Deficiency, Multiple Carboxylase Deficiency, and Thrombectomy.

His clinical research consists of co-authoring 103 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Multiple Carboxylase Deficiency.

Gender
Male

Locations

CHU d'Amiens
Amiens, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Enrollment Status: Recruiting
Publish Date: March 12, 2025
Intervention Type: Other
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological, Drug, Other
Study Drugs: Vitamin D, Lumbar Puncture, Blood Sampling, Urine Samples
Study Phase: Phase 3
View 1 Less Clinical Trial

103 Total Publications

Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning.
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gout's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile